Overexpression of CDCP1 is Associated with Poor Prognosis and Enhanced Immune Checkpoints Expressions in Breast Cancer

Figure 3

Prognostic value of CDCP1 in BrCa patients. (a, b, c) RFS, OS, and DMFS curves were plotted to assess the prognostic value of CDCP1 mRNA expression in BrCa using the Kaplan–Meier Plotter database. (d) Expression levels of CDCP1 in tumor tissues from alive and dead patients. (e) OS curves were plotted to evaluate the prognostic value of CDCP1 protein expression in the in-house cohort.

(a)

(b)

(c)

(d)

(e)